comprehensive -WSS

comprehensive

author：explore 2025-09-30 01:03:15 - browse：6161

Light hits on the portrait of George Washington on a one dollar bill. The portrait is surrounded by white and red tablets coming out of a pill bottle, as well as some coins — coverage from STAT — Adobe

WASHINGTON — Pharmaceutical companies are doing anything they can to stop President Biden’s Medicare program from being able to negotiate prices for their products, including suing the government. Experts say their efforts might actually benefit Biden by reminding voters that he’s taking on big drug companies.

When Democrats passed a law directing Medicare to negotiate drug prices, it was considered a major achievement. The new law, two decades in the making, gives Biden an accomplishment to both tout for himself and criticize Republicans for opposing — no Republicans voted to let Medicare negotiate drug prices.

Medicare price negotiation is popular with voters, as are the law’s price-inflation limits, and it includes additional, direct benefits for older adults that are easy to understand. It caps annual out-of-pocket retail-drug spending for seniors and people with disabilities, and it caps their monthly spending on insulin at $35.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： A pediatrician calls for Congress to pass the child tax credit deal

WSS

FDA approves Sage Therapeutics’ rapid

Dana Farber says 6 studies to be retracted and 31 corrected

TikTok, Instagram influencers need more rules for drug ads

Immunocompromised patients offer clues on chronic Covid

FAA sets up new process for Hawaii air tour operators to fly at lower altitudes after fatal crashes

The cancer stories no one wants to hear

leisure time

comprehensive

hotspot

Activists slam private health insurers over coverage restrictions

CDC recommends RSV monoclonal antibody for infants

Trump demands the U.S. pay no more for drugs than other countries … again

'Null' research findings aren't empty of meaning. Let's publish them

At least 13 dead in Texas as scorching temps continue

Medicare bonuses could stop drug shortages under Senate plan

Malaria cases in Florida and Texas: Here’s what you need to know

How I helped Pfizer think through the ethics of Viagra

Moonlake's readout produced a cash windfall. Risks remain

Physicians aren't 'burning out.' They're suffering from moral injury

entertainment

Listen: Biotech layoffs, eye drug drama, & gene therapy milestones

Who is Jack Smith, the special counsel overseeing the DOJ's Trump probes?

FDA sets aggressive timeline for overhauling inspection procedures

2 officers injured in shooting in Orlando, police say

Prior authorization reform is both possible and imperative

Pharma showers House GOP doctor with campaign cash

hotspot

Wikipedia

hotspot

Wikipedia